STAT3 and hepatocellular carcinoma: A similar mechanism confers radioresistance also to hepatocellular carcinoma (HCC): the inhibition of IL-6 signaling increases the radiotherapy-induced cell death, and this is associated with decreased phosphorylation of STAT3 (76).